These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 28284262)
1. Respiratory medication use in primary care among COPD subjects in four Latin American countries. Jardim JR; Stirbulov R; Moreno D; Zabert G; Lopez-Varela MV; Montes de Oca M Int J Tuberc Lung Dis; 2017 Apr; 21(4):458-465. PubMed ID: 28284262 [TBL] [Abstract][Full Text] [Related]
2. Bronchodilator treatment for COPD in primary care of four Latin America countries: The multinational, cross-sectional, non-interventional PUMA study. Montes de Oca M; Lopez Varela MV; Jardim J; Stirvulov R; Surmont F Pulm Pharmacol Ther; 2016 Jun; 38():10-6. PubMed ID: 27113029 [TBL] [Abstract][Full Text] [Related]
3. Asthma-COPD overlap syndrome (ACOS) in primary care of four Latin America countries: the PUMA study. Montes de Oca M; Victorina Lopez Varela M; Laucho-Contreras ME; Casas A; Schiavi E; Mora JC BMC Pulm Med; 2017 Apr; 17(1):69. PubMed ID: 28431499 [TBL] [Abstract][Full Text] [Related]
4. COPD Underdiagnosis and Misdiagnosis in a High-Risk Primary Care Population in Four Latin American Countries. A Key to Enhance Disease Diagnosis: The PUMA Study. Casas Herrera A; Montes de Oca M; López Varela MV; Aguirre C; Schiavi E; Jardim JR; PLoS One; 2016; 11(4):e0152266. PubMed ID: 27073880 [TBL] [Abstract][Full Text] [Related]
5. Detection of COPD in a high-risk population: should the diagnostic work-up include bronchodilator reversibility testing? Kjeldgaard P; Dahl R; Løkke A; Ulrik CS Int J Chron Obstruct Pulmon Dis; 2015; 10():407-14. PubMed ID: 25759573 [TBL] [Abstract][Full Text] [Related]
6. Development of a simple screening tool for opportunistic COPD case finding in primary care in Latin America: The PUMA study. López Varela MV; Montes de Oca M; Rey A; Casas A; Stirbulov R; Di Boscio V; Respirology; 2016 Oct; 21(7):1227-34. PubMed ID: 27319305 [TBL] [Abstract][Full Text] [Related]
7. Use of respiratory medication in five Latin American cities: The PLATINO study. Montes de Oca M; Tálamo C; Perez-Padilla R; Lopez MV; Muiño A; Jardim JR; Valdivia G; Pertuzé J; Moreno D; Halbert RJ; Menezes AM; Pulm Pharmacol Ther; 2008 Oct; 21(5):788-93. PubMed ID: 18621136 [TBL] [Abstract][Full Text] [Related]
8. Exacerbations and health care resource utilization in patients with airflow limitation diseases attending a primary care setting: the PUMA study. Montes de Oca M; Aguirre C; Lopez Varela MV; Laucho-Contreras ME; Casas A; Surmont F Int J Chron Obstruct Pulmon Dis; 2016; 11():3059-3067. PubMed ID: 27994446 [TBL] [Abstract][Full Text] [Related]
9. External validation of the PUMA COPD diagnostic questionnaire in a general practice sample and the PLATINO study population. Lopez Varela MV; Montes de Oca M; Wehrmeister FC; Rodriguez C; Ramirez L; Menezes A Int J Chron Obstruct Pulmon Dis; 2019; 14():1901-1911. PubMed ID: 31692595 [TBL] [Abstract][Full Text] [Related]
10. Characteristics of undertreatment in COPD in the general population. Ingebrigtsen TS; Marott JL; Vestbo J; Hallas J; Nordestgaard BG; Dahl M; Lange P Chest; 2013 Dec; 144(6):1811-1818. PubMed ID: 23989916 [TBL] [Abstract][Full Text] [Related]
11. Pre- and post-bronchodilator airway obstruction are associated with similar clinical characteristics but different prognosis - report from a population-based study. Sawalha S; Hedman L; Rönmark E; Lundbäck B; Lindberg A Int J Chron Obstruct Pulmon Dis; 2017; 12():1269-1277. PubMed ID: 28490870 [TBL] [Abstract][Full Text] [Related]
12. Effects of roflumilast in COPD patients receiving inhaled corticosteroid/long-acting β2-agonist fixed-dose combination: RE(2)SPOND rationale and study design. Rennard SI; Martinez FJ; Rabe KF; Sethi S; Pizzichini E; McIvor A; Siddiqui S; Anzueto A; Zhu H Int J Chron Obstruct Pulmon Dis; 2016; 11():1921-8. PubMed ID: 27574416 [TBL] [Abstract][Full Text] [Related]
13. Discriminative Accuracy of the CAPTURE Tool for Identifying Chronic Obstructive Pulmonary Disease in US Primary Care Settings. Martinez FJ; Han MK; Lopez C; Murray S; Mannino D; Anderson S; Brown R; Dolor R; Elder N; Joo M; Khan I; Knox LM; Meldrum C; Peters E; Spino C; Tapp H; Thomashow B; Zittleman L; Make B; Yawn BP; JAMA; 2023 Feb; 329(6):490-501. PubMed ID: 36786790 [TBL] [Abstract][Full Text] [Related]
14. Misdiagnosis of COPD and asthma in primary care patients 40 years of age and over. Tinkelman DG; Price DB; Nordyke RJ; Halbert RJ J Asthma; 2006; 43(1):75-80. PubMed ID: 16448970 [TBL] [Abstract][Full Text] [Related]
16. Inaccurate diagnosis of COPD: the Welsh National COPD Audit. Fisk M; McMillan V; Brown J; Holzhauer-Barrie J; Khan MS; Baxter N; Roberts CM Br J Gen Pract; 2019 Jan; 69(678):e1-e7. PubMed ID: 30559109 [TBL] [Abstract][Full Text] [Related]
17. Smoke, Biomass Exposure, and COPD Risk in the Primary Care Setting: The PUMA Study. Montes de Oca M; Zabert G; Moreno D; Laucho-Contreras ME; Lopez Varela MV; Surmont F Respir Care; 2017 Aug; 62(8):1058-1066. PubMed ID: 28559464 [TBL] [Abstract][Full Text] [Related]
18. Drop in lung function during asthma and COPD exacerbations - can it be assessed without spirometry? Melbye H; Al-Ani S; Spigt M Int J Chron Obstruct Pulmon Dis; 2016; 11():3145-3152. PubMed ID: 27994453 [TBL] [Abstract][Full Text] [Related]
19. Occurrence of respiratory symptoms in persons with restrictive ventilatory impairment compared with persons with chronic obstructive pulmonary disease: The PLATINO study. Nonato NL; Nascimento OA; Padilla RP; de Oca MM; Tálamo C; Valdivia G; Lisboa C; López MV; Celli B; Menezes AM; Jardim JR Chron Respir Dis; 2015 Aug; 12(3):264-73. PubMed ID: 26041119 [TBL] [Abstract][Full Text] [Related]
20. Bronchodilator response of advanced lung function parameters depending on COPD severity. Jarenbäck L; Eriksson G; Peterson S; Ankerst J; Bjermer L; Tufvesson E Int J Chron Obstruct Pulmon Dis; 2016; 11():2939-2950. PubMed ID: 27932874 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]